Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose

10. november 2026 oppdatert av: Hediye Karakoç, KTO Karatay University

The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study

This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.

Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.

The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.

Studieoversikt

Status

Fullført

Forhold

Studietype

Intervensjonell

Registrering (Faktiske)

72

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Karatay
      • Konya, Karatay, Tyrkia (Türkiye), 42040
        • KTO Karatay University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

7 måneder til 8 måneder (Barn)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • Within the first 28 days of life at enrollment.
  • Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • Birth weight of at least 1,500 g.
  • The infant's mother was able to provide expressed breast milk.
  • No clinical condition that precluded safe positioning or swaddling.
  • Written informed consent obtained from a parent.

Exclusion Criteria:

  • A painful procedure within 1 hour before the start of the planned study session.
  • Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • Previous surgery.
  • An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • Cerebral hypoxia or ischemia.
  • Intraventricular hemorrhage.
  • A major congenital anomaly.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Maternal Breast Milk Odor

Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.

Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.

Eksperimentell: Safe Swaddling

Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.

Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.

Ingen inngripen: Standard Care

Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Newborn Stress Scale Total Score Over Time
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Premature Infant Comfort Scale Total Score
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Heart Rate
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Heart rate was read directly from the bedside monitor and recorded in beats per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Respiratory Rate
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Peripheral Oxygen Saturation (SpO₂)
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Body Temperature
Tidsramme: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Hediye Karakoç, KTO Karatay Üniversitesi

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

28. juni 2024

Primær fullføring (Faktiske)

30. april 2026

Studiet fullført (Faktiske)

30. august 2026

Datoer for studieregistrering

Først innsendt

19. august 2025

Først innsendt som oppfylte QC-kriteriene

1. juli 2026

Først lagt ut (Faktiske)

2. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

13. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Security

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere